Peter Leonard Grant
Founder at FUSION IP PLC
Peter Leonard Grant active positions
Companies | Position | Start | End |
---|---|---|---|
FUSION IP PLC | Director/Board Member | 2004-11-30 | - |
Founder | 2001-12-31 | - | |
Chief Operating Officer | 2009-10-06 | - | |
Alesi Surgical Ltd.
Alesi Surgical Ltd. Medical SpecialtiesHealth Technology Alesi Surgical Ltd. is a holding company, which engages in the manufacture and development of medical devices. It focuses on minimally invasive surgery. Alesi works with surgeons to identify, resolve issues and develops techniques for the healthcare provider. Its Ultravision is a revolutionary new system that clears surgical smoke from the visual field and prevents its release into the operating theatre during laparoscopic surgery. The company was founded by Neil Warren in 2009 and is headquartered in Cardiff, the United Kingdom. | Director/Board Member | - | - |
Fusion Ip Sheffield Ltd.
Fusion Ip Sheffield Ltd. Miscellaneous Commercial ServicesCommercial Services Part of IP Group Plc, Fusion IP Sheffield Ltd. commercializes intellectual properties. The company is based in London, UK. | Director/Board Member | 2010-11-25 | - |
Fusion IP Cardiff Ltd.
Fusion IP Cardiff Ltd. Miscellaneous Commercial ServicesCommercial Services Part of IP Group Plc, Fusion IP Cardiff Ltd. engages in the commercialization of intellectual property. The company is based in London, UK. The British company was founded by Neil Warren. | Director/Board Member | - | - |
Career history of Peter Leonard Grant
Former positions of Peter Leonard Grant
Companies | Position | Start | End |
---|---|---|---|
PH Therapeutics Ltd.
PH Therapeutics Ltd. Medical/Nursing ServicesHealth Services PH Therapeutics Ltd. engages in the research and development of biological treatments. It develops novel antibody therapies to treat the orphan disease Pulmonary Arterial Hypertension. The company was founded in 2013 by Allan Lawrie and is headquartered in Leeds, the United Kingdom. | Director/Board Member | 2013-03-05 | 2020-01-30 |
Fusion IP (Private Equity)
Fusion IP (Private Equity) Investment ManagersFinance Fusion IP Private Equity (Fusion PE) is the private equity & Venture capital division of Fusion IP plc (LSE: FIP) in the United Kingdom founded in 2002. The firm headquartered in London, Yorkshire. | Director/Board Member | 2004-11-30 | - |
Chief Operating Officer | 2004-11-30 | - | |
Private Equity Investor | - | 2019-04-22 | |
FaultCurrent Ltd.
FaultCurrent Ltd. Electronic ComponentsElectronic Technology FaultCurrent Ltd. develops magnetic fault current limiter protection products. It offers passive magnetic fault current limiter (pmFCL), a Smart Grid technology that protects utility electrical distribution networks from unanticipated power surges and the new demands being placed on ageing and already overburdened electrical infrastructures from the connection of cleaner distributed energy sources. The company was founded by Jeremy Hall in 2012 and is headquartered in Caerphilly, the United Kingdom. | Director/Board Member | - | 2018-03-08 |
Axordia Ltd.
Axordia Ltd. Miscellaneous Commercial ServicesCommercial Services Axordia Ltd. develops human embryonic stem cell applications. Its applications include dry AMD, next generation stents, and GMP-compliant HESC lines. The company was founded by Peter W. Andrews and Harry Moore in 2001 and is headquartered in Sheffield, UK. | Director/Board Member | - | 2013-04-17 |
Phase Focus Ltd.
Phase Focus Ltd. Medical SpecialtiesHealth Technology Phase Focus Ltd. provides optical prototype instruments. It brings to market a range of products and services based on its proprietary Phasefocus Virtual Lens- a disruptive technology that is revolutionising the performance of imaging instrumentation and bringing new user value to analytical applications from stain-free cell imaging and quantitative electron phase microscopy to ophthalmic lens metrology and beyond. The firm's Virtual Lens enables the observation and analysis of materials, processes and products in new ways and with unprecedented clarity and accuracy. The company was founded in 2006 and is headquartered in Sheffield, the United Kingdom. | Director/Board Member | 2006-06-22 | 2008-01-31 |
Founder | 2006-06-22 | 2008-01-31 | |
░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - | - |
░░░░░░░ | - | - | |
░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - | - |
░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | ░░░░░░░░░░ |
░░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | - | - |
░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Training of Peter Leonard Grant
University of Cardiff | Doctorate Degree |
Statistics
International
United Kingdom | 22 |
Operational
Director/Board Member | 17 |
Founder | 3 |
Chairman | 3 |
Sectoral
Health Technology | 13 |
Commercial Services | 5 |
Health Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 20 |
---|---|
Fusion IP (Private Equity)
Fusion IP (Private Equity) Investment ManagersFinance Fusion IP Private Equity (Fusion PE) is the private equity & Venture capital division of Fusion IP plc (LSE: FIP) in the United Kingdom founded in 2002. The firm headquartered in London, Yorkshire. | Finance |
Axordia Ltd.
Axordia Ltd. Miscellaneous Commercial ServicesCommercial Services Axordia Ltd. develops human embryonic stem cell applications. Its applications include dry AMD, next generation stents, and GMP-compliant HESC lines. The company was founded by Peter W. Andrews and Harry Moore in 2001 and is headquartered in Sheffield, UK. | Commercial Services |
Genophrenix Ltd.
Genophrenix Ltd. BiotechnologyHealth Technology Genophrenix Ltd. discovered and developed proteins for neurological diseases. The company was founded on February 20, 2006 and was headquartered in Sheffield, the United Kingdom. | Health Technology |
Absynth Biologics Ltd.
Absynth Biologics Ltd. BiotechnologyHealth Technology Absynth Biologics Ltd. develops and manufactures immunological prophylaxis, novel vaccines and therapies. The company was founded by Simon J. Foster in 2007 and is headquartered in Alderley Edge, the United Kingdom. | Health Technology |
Mantelum Ltd.
Mantelum Ltd. BiotechnologyHealth Technology Mantelum Ltd. produced G-protein coupled receptor drugs. The company was founded in 2006 and was headquartered in Sheffield, the united kingdom. | Health Technology |
Medella Therapeutics Ltd.
Medella Therapeutics Ltd. BiotechnologyHealth Technology Medella Therapeutics Ltd. develops monoclonal antibody drugs for cancer. Its focus is on cancer, where the unmet need is for therapies that preferentially target cell signaling in cancer cells, offering advantages over drugs marketed and in clinical development. The company was founded by Kim Skerry and Gareth Richards in May 2007 and is headquartered in Sheffield, the United Kingdom. | Health Technology |
Adjuvantix Ltd.
Adjuvantix Ltd. BiotechnologyHealth Technology Adjuvantix Ltd. engages in the research and development of vaccines for the treatment of cancer and infectious diseases. Its initial vaccine development targets include prostate cancer, lymphoma and TB. The company's products include ADX40-TB, ADX40-prostate cancer and ADX40-lymphoma. Adjuvantix was founded by Andrew John William Heath on October 28, 1999 and is headquartered in Sheffield, the United Kingdom. | Health Technology |
Asterion Ltd.
Asterion Ltd. BiotechnologyHealth Technology Asterion Ltd. develops novel therapeutic products. It offers drugs for patients with chronic, debilitating diseases. The company was founded by Richard John Martin Ross, Peter Artymiuk and Jon R. Sayers in 2001 and is headquartered in Sheffield, the United Kingdom. | Health Technology |
Diurnal Group Ltd.
Diurnal Group Ltd. Pharmaceuticals: MajorHealth Technology Diurnal Group plc engages in the development of products for the life-long treatment of chronic endocrine conditions, including congenital adrenal hyperplasia and adrenal insufficiency. It focuses on circadian-based endocrinology to yield novel product candidates in the rare and chronic endocrine disease arena. The company was founded by Richard John Martin Ross in 2004 and is headquartered in Cardiff, the United Kingdom. | Health Technology |
Celltran Ltd.
Celltran Ltd. Pharmaceuticals: MajorHealth Technology Celltran Ltd. develops cell therapy products for wound healing and skin regeneration. It develops polymer surface technology and methods for the culture of autologous and allogeneic cells. The company was founded in 2000 by Sheila MacNeil and Robert Short and is headquartered in Sheffield, UK. | Health Technology |
Chiros Ltd.
Chiros Ltd. Pharmaceuticals: OtherHealth Technology Part of Dow, Inc., Chiros Ltd. is a chemical research and British development company. The company is based in Cambridge, UK. | Health Technology |
Celsis International Ltd.
Celsis International Ltd. Medical SpecialtiesHealth Technology Celsis International Ltd. develops and supplies medical diagnostic products and laboratory services. The company was founded by Sir Christopher Evans in 1992 and is headquartered in Westminster, the United Kingdom. | Health Technology |
Fusion IP Ltd.
Fusion IP Ltd. Miscellaneous Commercial ServicesCommercial Services Fusion IP Ltd. operates as a holding company. It engages in the commercialization of intellectual properties that is developed at universities and similar establishments. The company was founded by Peter Leonard Grant, Stewart Gall and David Graham Baynes in 2002 and is headquartered in Sheffield, the United Kingdom. | Commercial Services |
Fusion Ip Sheffield Ltd.
Fusion Ip Sheffield Ltd. Miscellaneous Commercial ServicesCommercial Services Part of IP Group Plc, Fusion IP Sheffield Ltd. commercializes intellectual properties. The company is based in London, UK. | Commercial Services |
Progenteq Ltd.
Progenteq Ltd. Medical/Nursing ServicesHealth Services Progenteq Ltd. develops a novel cartiledge replacement therapy to revolutionize the treatment of acute knee injuries. The company was founded on November 29, 2009 and is headquartered in Cardiff, the United Kingdom. | Health Services |
PH Therapeutics Ltd.
PH Therapeutics Ltd. Medical/Nursing ServicesHealth Services PH Therapeutics Ltd. engages in the research and development of biological treatments. It develops novel antibody therapies to treat the orphan disease Pulmonary Arterial Hypertension. The company was founded in 2013 by Allan Lawrie and is headquartered in Leeds, the United Kingdom. | Health Services |
FaultCurrent Ltd.
FaultCurrent Ltd. Electronic ComponentsElectronic Technology FaultCurrent Ltd. develops magnetic fault current limiter protection products. It offers passive magnetic fault current limiter (pmFCL), a Smart Grid technology that protects utility electrical distribution networks from unanticipated power surges and the new demands being placed on ageing and already overburdened electrical infrastructures from the connection of cleaner distributed energy sources. The company was founded by Jeremy Hall in 2012 and is headquartered in Caerphilly, the United Kingdom. | Electronic Technology |
Phase Focus Ltd.
Phase Focus Ltd. Medical SpecialtiesHealth Technology Phase Focus Ltd. provides optical prototype instruments. It brings to market a range of products and services based on its proprietary Phasefocus Virtual Lens- a disruptive technology that is revolutionising the performance of imaging instrumentation and bringing new user value to analytical applications from stain-free cell imaging and quantitative electron phase microscopy to ophthalmic lens metrology and beyond. The firm's Virtual Lens enables the observation and analysis of materials, processes and products in new ways and with unprecedented clarity and accuracy. The company was founded in 2006 and is headquartered in Sheffield, the United Kingdom. | Health Technology |
Alesi Surgical Ltd.
Alesi Surgical Ltd. Medical SpecialtiesHealth Technology Alesi Surgical Ltd. is a holding company, which engages in the manufacture and development of medical devices. It focuses on minimally invasive surgery. Alesi works with surgeons to identify, resolve issues and develops techniques for the healthcare provider. Its Ultravision is a revolutionary new system that clears surgical smoke from the visual field and prevents its release into the operating theatre during laparoscopic surgery. The company was founded by Neil Warren in 2009 and is headquartered in Cardiff, the United Kingdom. | Health Technology |
Fusion IP Cardiff Ltd.
Fusion IP Cardiff Ltd. Miscellaneous Commercial ServicesCommercial Services Part of IP Group Plc, Fusion IP Cardiff Ltd. engages in the commercialization of intellectual property. The company is based in London, UK. The British company was founded by Neil Warren. | Commercial Services |
- Stock Market
- Insiders
- Peter Leonard Grant
- Experience